Primary |
Smoking Cessation Therapy |
57.8% |
Tobacco User |
7.1% |
Hypertension |
6.6% |
Depression |
4.9% |
Nicotine Dependence |
2.5% |
Asthma |
2.2% |
Insomnia |
2.1% |
Anxiety |
1.9% |
Chronic Obstructive Pulmonary Disease |
1.9% |
Diabetes Mellitus |
1.9% |
Ex-smoker |
1.6% |
Tobacco Abuse |
1.5% |
Blood Cholesterol Increased |
1.4% |
Pain |
1.2% |
Cardiac Disorder |
1.0% |
Bronchitis |
1.0% |
Contraception |
1.0% |
Hypothyroidism |
0.9% |
Sleep Disorder |
0.8% |
Blood Cholesterol |
0.7% |
|
Suicidal Ideation |
13.9% |
Vomiting |
11.9% |
Nausea |
11.4% |
Weight Increased |
5.3% |
Weight Decreased |
5.2% |
Suicide Attempt |
5.1% |
Nervousness |
5.1% |
Tremor |
4.4% |
Somnolence |
4.3% |
Tearfulness |
3.9% |
Depression |
3.8% |
Sleep Disorder |
3.4% |
Withdrawal Syndrome |
3.3% |
Paranoia |
2.9% |
Mental Disorder |
2.8% |
Syncope |
2.8% |
Malaise |
2.7% |
Panic Attack |
2.7% |
Vision Blurred |
2.7% |
Hypertension |
2.3% |
|
Secondary |
Smoking Cessation Therapy |
32.6% |
Tobacco User |
10.0% |
Hypertension |
8.2% |
Nicotine Dependence |
7.4% |
Depression |
6.6% |
Insomnia |
5.1% |
Anxiety |
3.8% |
Product Used For Unknown Indication |
3.8% |
Diabetes Mellitus |
2.5% |
Tobacco Abuse |
2.4% |
Bronchitis |
2.2% |
Blood Cholesterol Increased |
2.1% |
Drug Use For Unknown Indication |
2.1% |
Cardiac Disorder |
2.0% |
Asthma |
1.8% |
Hypothyroidism |
1.7% |
Ex-tobacco User |
1.6% |
Gastritis |
1.5% |
Sleep Disorder |
1.4% |
Antidepressant Therapy |
1.3% |
|
Nausea |
13.7% |
Nervousness |
12.1% |
Vomiting |
10.2% |
Weight Increased |
8.3% |
Suicidal Ideation |
7.9% |
Weight Decreased |
5.8% |
Tremor |
5.5% |
Somnolence |
4.9% |
Withdrawal Syndrome |
4.3% |
Malaise |
4.0% |
Suicide Attempt |
4.0% |
Blood Pressure Increased |
2.8% |
Hypertension |
2.8% |
Bronchitis |
2.1% |
Retching |
2.1% |
Toxic Skin Eruption |
2.1% |
Vision Blurred |
2.1% |
Epilepsy |
1.9% |
Palpitations |
1.9% |
Liver Disorder |
1.7% |
|
Concomitant |
Product Used For Unknown Indication |
40.1% |
Pain |
9.2% |
Diabetes Mellitus |
8.0% |
Hypertension |
6.9% |
Hypercholesterolaemia |
6.0% |
Hepatitis B |
3.4% |
Hiv Infection |
2.9% |
Ex-tobacco User |
2.6% |
Postoperative Care |
2.6% |
Back Pain |
2.3% |
Gastritis |
2.0% |
Smoking Cessation Therapy |
2.0% |
Chronic Myeloid Leukaemia |
1.7% |
Crohn's Disease |
1.7% |
Drug Use For Unknown Indication |
1.7% |
Rheumatoid Arthritis |
1.7% |
Abdominal Pain |
1.4% |
Depression |
1.4% |
Immune Thrombocytopenic Purpura |
1.1% |
Osteoporosis |
1.1% |
|
Vomiting |
15.1% |
Urticaria |
13.2% |
Suicidal Ideation |
9.4% |
Iron Deficiency Anaemia |
7.5% |
Cerebral Thrombosis |
5.7% |
Gastrointestinal Haemorrhage |
5.7% |
Monocyte Count Increased |
5.7% |
Mania |
3.8% |
Myositis |
3.8% |
Nausea |
3.8% |
Non-small Cell Lung Cancer Metastatic |
3.8% |
Pneumonia Aspiration |
3.8% |
Ureteric Cancer |
3.8% |
Vision Blurred |
3.8% |
Anaemia |
1.9% |
Blood Pressure Decreased |
1.9% |
Cd4 Lymphocytes Decreased |
1.9% |
Dissociative Disorder |
1.9% |
Head Injury |
1.9% |
Henoch-schonlein Purpura |
1.9% |
|
Interacting |
Smoking Cessation Therapy |
23.9% |
Bipolar Disorder |
9.2% |
Product Used For Unknown Indication |
9.2% |
Influenza |
8.0% |
Depression |
6.1% |
Hypertension |
5.5% |
Nicotine Dependence |
4.9% |
Sinusitis |
4.9% |
Tobacco User |
4.3% |
Myoclonus |
3.7% |
Acute Sinusitis |
3.1% |
Oropharyngeal Pain |
3.1% |
Relaxation Therapy |
2.5% |
Back Pain |
1.8% |
Ex-tobacco User |
1.8% |
Major Depression |
1.8% |
Multiple Sclerosis |
1.8% |
Tobacco Abuse |
1.8% |
Anxiety |
1.2% |
Blood Cholesterol Increased |
1.2% |
|
Drug Interaction |
17.4% |
Withdrawal Syndrome |
17.4% |
Nausea |
8.7% |
Epilepsy |
6.5% |
Potentiating Drug Interaction |
6.5% |
Hallucination |
4.3% |
Poisoning |
4.3% |
Suicidal Ideation |
4.3% |
Unresponsive To Stimuli |
4.3% |
Vasculitis |
4.3% |
Aggression |
2.2% |
Asthenia |
2.2% |
Drug Level Below Therapeutic |
2.2% |
Extra Dose Administered |
2.2% |
Increased Appetite |
2.2% |
Injury |
2.2% |
Pregnancy With Contraceptive Device |
2.2% |
Road Traffic Accident |
2.2% |
Somnolence |
2.2% |
Speech Disorder |
2.2% |
|